ACTIVITY OF TERBINAFINE AGAINST PNEUMOCYSTIS-CARINII IN-VITRO AND ITS EFFICACY IN THE TREATMENT OF EXPERIMENTAL PNEUMONIA

被引:23
作者
CONTINI, C
MANGANARO, M
ROMANI, R
TZANTZOGLOU, S
POGGESI, I
VULLO, V
DELIA, S
DESIMONE, C
机构
[1] UNIV ROMA LA SAPIENZA, INST INFECT & TROP DIS, ROME, ITALY
[2] UNIV ROMA LA SAPIENZA, INST INFECT DIS, ROME, ITALY
[3] UNIV LAQUILA, INST INFECT DIS, I-67100 LAQUILA, ITALY
关键词
D O I
10.1093/jac/34.5.727
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The antiprotozoan and antifungal agent, the terbinafine, was investigated for its potential activity against Pneumocystis carinii infection of the A549 cell line culture and on immunosuppressed Sprague Dawley rats in comparison with trimethoprim-sulphamethoxazole and pentamidine isethionate. Terbinafine suppressed P. carinii growth at doses up to 3 g/L within 24 h and it was able to inhibit cyst forms at 60 h post inoculation. With respect to trimethoprim-sulphamethoxazole raze le and pentamidine isethionate P. carinii organisms decreased at the same time interval but cyst form elimination was less apparent than with terbinafine. The results of the in-vitro culture were consistent with the in-vivo observations. Of the 3 groups of rats tested, the occurrence of P. carinii pneumonia was documented in 18 (60%) of the control rats (group 3) which showed a high degree of P. carinii burden and a marked weight loss with respect to the beginning of the experiment. Among terbinafine treated rats (group 1), P. carinii pneumonia was present in one rat (3.3%), while no P. carinii infection occurred in the pentamidine isethionate and in trimethoprim-sulphamethoxazole treatment rat groups (group 2). All the agents investigated showed no particular signs of toxicity. These preliminary results suggest further explorations of the terbinafine in clinical trials for treatment and prophylaxis of P. carinii pneumonia.
引用
收藏
页码:727 / 735
页数:9
相关论文
共 21 条
[1]   TERBINAFINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL MYCOSES [J].
BALFOUR, JA ;
FAULDS, D .
DRUGS, 1992, 43 (02) :259-284
[2]   INVITRO ANTILEISHMANIAL ACTIVITY OF INHIBITORS OF STEROID-BIOSYNTHESIS AND COMBINATIONS OF ANTILEISHMANIAL AGENTS [J].
BERMAN, JD ;
GALLALEE, JV .
JOURNAL OF PARASITOLOGY, 1987, 73 (03) :671-673
[3]   METHOD OF TESTING THE SUSCEPTIBILITY OF PNEUMOCYSTIS-CARINII TO ANTIMICROBIAL AGENTS INVITRO [J].
CUSHION, MT ;
STANFORTH, D ;
LINKE, MJ ;
WALZER, PD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (06) :796-801
[4]   GROWTH AND SERIAL PASSAGE OF PNEUMOCYSTIS-CARINII IN THE A549 CELL-LINE [J].
CUSHION, MT ;
WALZER, PD .
INFECTION AND IMMUNITY, 1984, 44 (02) :245-251
[5]  
FRENKEL JK, 1966, LAB INVEST, V15, P1559
[6]   EFFECT OF THE ALLYLAMINE ANTIFUNGAL DRUG SF 86-327 ON THE GROWTH AND STEROL SYNTHESIS OF LEISHMANIA-MEXICANA-MEXICANA PROMASTIGOTES [J].
GOAD, LJ ;
HOLZ, GG ;
BEACH, DH .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (20) :3785-3788
[7]  
HUGHES WT, 1974, J PEDIATRIES, V92, P285
[8]  
KOVACS JA, 1986, LANCET, V2, P1
[9]   PNEUMOCYSTIS PNEUMONIA - FROM BENCH TO CLINIC [J].
MASUR, H ;
LANE, HC ;
KOVACS, JA ;
ALLEGRA, CJ ;
EDMAN, JC .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (10) :813-826
[10]  
Nato F, 1992, Eur J Med, V1, P132